TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 24 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $56 | -12.5% | 135,310 | -0.3% | 0.00% | – |
Q3 2023 | $64 | -27.3% | 135,710 | +0.1% | 0.00% | – |
Q2 2023 | $88 | -21.4% | 135,610 | +0.1% | 0.00% | – |
Q1 2023 | $112 | +6.7% | 135,410 | +0.7% | 0.00% | – |
Q4 2022 | $105 | -99.9% | 134,410 | -7.1% | 0.00% | – |
Q3 2022 | $156,000 | +15.6% | 144,710 | -39.9% | 0.00% | – |
Q2 2022 | $135,000 | +285.7% | 240,710 | +559.3% | 0.00% | – |
Q1 2022 | $35,000 | +75.0% | 36,510 | +87.1% | 0.00% | – |
Q4 2021 | $20,000 | -16.7% | 19,510 | +50.1% | 0.00% | – |
Q3 2021 | $24,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 39,820 | $119,000 | 0.02% |
Westside Investment Management, Inc. | 8 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 138 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 46 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 23,459 | $70,000 | 0.00% |
Sowell Financial Services LLC | 19 | $0 | 0.00% |
CREDIT SUISSE AG/ | 23,200 | $69,000 | 0.00% |
OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |
Rockefeller Capital Management L.P. | 5 | $0 | 0.00% |